4//SEC Filing
Xavier Ramnik 4
Accession 0001213900-23-048203
CIK 0001821586other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:55 PM ET
Size
5.5 KB
Accession
0001213900-23-048203
Insider Transaction Report
Form 4
Xavier Ramnik
Director
Transactions
- Award
Option to Buy
2023-06-08+11,297→ 11,297 totalExercise: $29.18Exp: 2033-06-08→ Class A ordinary shares, par value $0.0001 per share (11,297 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920780
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:55 PM ET
- Size
- 5.5 KB